---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-004108"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2024-01-12T23:59:59+00:00"
generated_at: "2026-06-07T00:02:17.454626+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics terminates credit agreement with Prime Capital Ventures, expects return of $5.25M deposit

## Summary
- Terminated credit agreement dated April 2023 with Prime Capital Ventures due to repeated funding delays.
- No borrowings under the agreement; no penalties incurred for termination.
- Company entitled to return of $5.25 million deposit placed for interest reserve.
- Agreement was intended to finance building manufacturing facility and upgrading labs in Miramar, Florida.
- HCW is seeking alternative financing to continue building project with minimal delays.

## SEC filing metadata
- accession: 0000950170-24-004108
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2024-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000095017024004108/0000950170-24-004108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000095017024004108/hcwb-20240112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-004108
- JSON: https://secwatch.observer/filing/0000950170-24-004108.json
- Plain text: https://secwatch.observer/filing/0000950170-24-004108.txt

## Key facts
- Material Agreements
  HCW Biologics Inc. terminated Credit Agreement with Prime Capital Ventures, LLC valued at No borrowings outstanding; $5.25 million deposit to be returned (effective 2024-01-10).
  - Action: termination
  - Agreement: credit facility
  - Counterparty: Prime Capital Ventures, LLC
  - Value: No borrowings outstanding; $5.25 million deposit to be returned
  - Effective: 2024-01-10
  source text: On January 10, 2024, HCW Biologics Inc. (the "Company") exercised its right to terminate its credit agreement (the "Agreement"), dated April 21, 2023, with Prime Capital Ventures, LLC (the "Lender"), as permitted under the terms of the Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1828673/000095017024004108/0000950170-24-004108-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.